The global athlete’s foot drugs market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). The athlete’s foot also known as tinea pedis is a fungal skin infection. It usually begins between the toes and occurs in people whose feet have become very sweaty while confined within tight-fitting shoes. The athlete’s foot drug is used to treat fungal infection of the feet that causes the scaling and blistering of the soles, fissures at toes as well as painful and burning sensations along itching rashes. The major factor for the growth of the market is the increasing prevalence and rise in incidence rates of athlete’s foot globally.
According to the National Center for Biotechnology Information (NCBI), an athlete’s foot is very common with an affection rate of an estimated 3 to 15% of the population. Additionally, as per the same source, men and older people are more likely to get it. Hence, the increasing prevalence of this infection is driving the growth of the global athlete’s foot drugs market during the forecast period. Furthermore, the market is propelling owing to the easy availability of over-the-counter (OTC) treatment coupled with the low cost of treatment.
To Request a Sample of our Report on Athlete’s Foot Drugs Market: https://www.omrglobal.com/request-sample/athletes-foot-drugs-market
Some major players in the global athlete’s foot drugs market include Mylan N.V., Novartis International AG, and Pfizer Inc., among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in April 2021, Pfizer Inc. acquired Amplyx Pharmaceuticals. The acquisition was aimed to develop a new treatment for drug-resistant “superbug” for antifungal treatment.
Market Coverage
- The market number available for – 2020-2027
- Base year- 2020
- Forecast period- 2022-2028
- Segment Covered-
- By Type
- By Treatment
- Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
- Competitive Landscape- Mylan N.V., Novartis International AG, and Pfizer Inc., among others.
A full Report of Athlete’s Foot Drugs Market is Available @ https://www.omrglobal.com/industry-reports/athletes-foot-drugs-market
Global Athlete’s Foot Drugs Market Report by Segment
By Type
- Interdigital
- Mocassin
- Vesicular
By Treatment
- Topical
- Oral Antifungal Medication
- Topical Oral Steroid
- Oral Antibiotics
Global Athlete’s Foot Drugs Market Report by Region
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of the World
- Latin America
- Middle East & Africa
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
